Modelling the impact of hybrid immunity on future COVID-19 epidemic waves

Author:

Le Thao P.ORCID,Abell IsobelORCID,Conway EamonORCID,Campbell Patricia T.ORCID,Hogan Alexandra B.ORCID,Lydeamore Michael J.ORCID,McVernon JodieORCID,Mueller IvoORCID,Walker Camelia R.ORCID,Baker Christopher M.ORCID

Abstract

AbstractSince the emergence of SARS-CoV-2 (COVID-19), there have been multiple waves of infection and multiple rounds of vaccination rollouts. Both prior infection and vaccination can prevent future infection and reduce severity of outcomes, combining to form hybrid immunity against COVID-19 at the individual and population level. Here, we explore how different combinations of hybrid immunity affect the size and severity of near-future Omicron waves. To investigate the role of hybrid immunity, we use an agent-based model of COVID-19 transmission with waning immunity to simulate outbreaks in populations with varied past attack rates and past vaccine coverages, basing the demographics and past histories on the World Health Organization (WHO) Western Pacific Region (WPR). We find that if the past infection immunity is high but vaccination levels are low, then the secondary outbreak with the same variant can occur within a few months after the first outbreak; meanwhile, high vaccination levels can suppress near-term outbreaks and delay the second wave. Additionally, hybrid immunity has limited impact on future COVID-19 waves with immune-escape variants. Enhanced understanding of the interplay between infection and vaccine exposure can aid anticipation of future epidemic activity due to current and emergent variants, including the likely impact of responsive vaccine interventions.

Publisher

Cold Spring Harbor Laboratory

Reference73 articles.

1. Tracking SARS-CoV-2 variants, Accessed 2022. URL: https://www.who.int/activities/tracking-SARS-CoV-2-variants.

2. Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar

3. World Health Organization. 2022. WHO Reference Number: WHO/2019-nCoV/Vaccines/SAGE/Prioritization/2022.1. URL: https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccines-SAGE-Prioritization-2022.1.

4. Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update. URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.

5. World Health Organization. Interim statement on hybrid immunity and increasing population seroprevalence rates, 2022. URL: https://www.who.int/news/item/01-06-2022-interim-statement-on-hybrid-immunity-and-increasing-population-seroprevalence

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3